Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stamp

Showing results (191-200 of 323) with videos related to

Pageof 33
Sort By:
Arthritis Care & Research|May 3, 2017
Education Preferences of People With Gout: Exploring Differences Between Indigenous and Nonindigenous Peoples from Rural and Urban LocationsGareth J Treharne, Aimee C Richardson, Tia Neha, et al.
Rheumatology (Oxford, England)|July 21, 2012
Myeloperoxidase and oxidative stress in rheumatoid arthritisLisa K Stamp, Irada Khalilova, Joanna M Tarr, et al.
BMC Medical Genetics|November 17, 2016
Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1AMurray Cadzow, Tony R Merriman, James Boocock, et al.
Trials|October 11, 2015
Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trialBen Hudson, Jonathan A Williman, Lisa K Stamp, et al.
Internal Medicine Journal|January 3, 2013
Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communitiesL K Stamp, J E Wells, S Pitama, et al.
Rheumatology (Oxford, England)|January 18, 2018
Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysisMary C Wallace, Rebecca L Roberts, Payal Nanavati, et al.
Clinical and Translational Science|November 18, 2022
The impact of genetic variability in urate transporters on oxypurinol pharmacokineticsHailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Arthritis Research & Therapy|April 29, 2021
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature reviewHuai Leng Pisaniello, Mark C Fisher, Hamish Farquhar, et al.
Plos One|February 1, 2022
Is repeat serum urate testing superior to a single test to predict incident gout over time?Sarah Stewart, Amanda Phipps-Green, Greg D Gamble, et al.
European Journal of Clinical Pharmacology|September 30, 2016
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysisDaniel Fb Wright, Matthew P Doogue, Murray L Barclay, et al.
Pageof 33

Showing results (191-200 of 323) with videos related to

Sort By:
Pageof 33
Arthritis Care & Research|May 3, 2017
Education Preferences of People With Gout: Exploring Differences Between Indigenous and Nonindigenous Peoples from Rural and Urban LocationsGareth J Treharne, Aimee C Richardson, Tia Neha, et al.
Rheumatology (Oxford, England)|July 21, 2012
Myeloperoxidase and oxidative stress in rheumatoid arthritisLisa K Stamp, Irada Khalilova, Joanna M Tarr, et al.
BMC Medical Genetics|November 17, 2016
Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1AMurray Cadzow, Tony R Merriman, James Boocock, et al.
Trials|October 11, 2015
Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trialBen Hudson, Jonathan A Williman, Lisa K Stamp, et al.
Internal Medicine Journal|January 3, 2013
Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communitiesL K Stamp, J E Wells, S Pitama, et al.
Rheumatology (Oxford, England)|January 18, 2018
Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysisMary C Wallace, Rebecca L Roberts, Payal Nanavati, et al.
Clinical and Translational Science|November 18, 2022
The impact of genetic variability in urate transporters on oxypurinol pharmacokineticsHailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Arthritis Research & Therapy|April 29, 2021
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature reviewHuai Leng Pisaniello, Mark C Fisher, Hamish Farquhar, et al.
Plos One|February 1, 2022
Is repeat serum urate testing superior to a single test to predict incident gout over time?Sarah Stewart, Amanda Phipps-Green, Greg D Gamble, et al.
European Journal of Clinical Pharmacology|September 30, 2016
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysisDaniel Fb Wright, Matthew P Doogue, Murray L Barclay, et al.
Pageof 33